POMDOCTOR director files initial insider Form 3

POMDOCTOR Ltd director Jing Yuanyuan Crystal filed an initial Form 3, which is a mandatory disclosure of insider status.

Rhea-AI Filing Summary

POMDOCTOR Ltd director Jing Yuanyuan Crystal filed an initial Form 3, which is a mandatory disclosure of insider status. The filing shows no reported transactions or share holdings at this time, serving only to register her as a reporting insider of the company.

Key Figures

Net buy/sell shares: 0 shares

1 metrics

Net buy/sell shares 0 shares Net insider trading activity reported in this Form 3

Key Terms

Form 3, reporting insider, ten percent owner

3 terms

Form 3 regulatory

"filed an initial Form 3, which is a mandatory disclosure"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting insider regulatory

"serving only to register her as a reporting insider"

ten percent owner financial

"She is not listed as an officer or ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does POMDOCTOR Ltd (POM) disclose in this Form 3?

POMDOCTOR Ltd discloses that Jing Yuanyuan Crystal is a director and reporting insider. The Form 3 contains no listed transactions or holdings, functioning as an initial status filing for regulatory compliance.

Who is the reporting person in the POM Form 3 filing?

The reporting person is Jing Yuanyuan Crystal, identified as a director of POMDOCTOR Ltd. She is not listed as an officer or ten percent owner, and the filing reports no transactions or share positions.

Does the POM Form 3 show any insider buying or selling?

No, the Form 3 shows no insider buying or selling. Transaction counts and share amounts for buys, sells, exercises, gifts, and other actions are all zero, indicating no reportable trades at the time of this filing.

Does Jing Yuanyuan Crystal report any share ownership in POM?

The Form 3 does not list any share or derivative holdings for Jing Yuanyuan Crystal. Holding entries and derivative summaries are empty, so only her status as a director and reporting person is recorded in this filing.

Is Jing Yuanyuan Crystal a ten percent owner of POMDOCTOR Ltd?

According to the Form 3, Jing Yuanyuan Crystal is not a ten percent owner of POMDOCTOR Ltd. She is classified solely as a director, with no additional roles or large ownership stake disclosed in this filing.

What is the purpose of this Form 3 for POMDOCTOR Ltd (POM)?

This Form 3 serves as an initial beneficial ownership report for a new insider. It brings director Jing Yuanyuan Crystal under ongoing reporting requirements, even though no transactions or specific holdings are disclosed at this stage.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 06:45 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jing Yuanyuan Crystal

(Last) (First) (Middle)

BUILDING 2, NO.41

NANSHILIJU ROAD CHAOYANG DISTRICT

(Street)

BEIJING BEIJING 100025

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
POMDOCTOR Ltd [ POM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Yuanyuan Jing	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)